| Host: |
Mouse |
| Applications: |
WB/ELISA |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Mouse monoclonal antibody anti-Ephrin type-A receptor 6 (695-795 aa) is suitable for use in Western Blot and ELISA research applications. |
| Clonality: |
Monoclonal |
| Clone ID: |
3D5B10 |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG1 |
| Formulation: |
Liquid in PBS containing 0.03% Sodium Azide, 0.5% BSA, 50% Glycerol. |
| Purification: |
Affinity purification |
| Dilution Range: |
WB 1:500-1:2000ELISA 1:10000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
EPHA6 |
| Gene ID: |
285220 |
| Uniprot ID: |
EPHA6_HUMAN |
| Immunogen Region: |
695-795 aa |
| Specificity: |
EphA6 Monoclonal Antibody detects endogenous levels of EphA6 protein. |
| Immunogen: |
Purified recombinant fragment of EphA6 (aa695-795) expressed in E. Coli. |
| Function | Receptor tyrosine kinase which binds promiscuously GPI-anchored ephrin-A family ligands residing on adjacent cells, leading to contact-dependent bidirectional signaling into neighboring cells. The signaling pathway downstream of the receptor is referred to as forward signaling while the signaling pathway downstream of the ephrin ligand is referred to as reverse signaling. |
| Protein Name | Ephrin Type-A Receptor 6Eph Homology Kinase 2Ehk-2Eph-Like Kinase 12Ek12 |
| Database Links | Reactome: R-HSA-2682334Reactome: R-HSA-3928663Reactome: R-HSA-3928665 |
| Cellular Localisation | MembraneSingle-Pass Type I Membrane Protein |
| Alternative Antibody Names | Anti-Ephrin Type-A Receptor 6 antibodyAnti-Eph Homology Kinase 2 antibodyAnti-Ehk-2 antibodyAnti-Eph-Like Kinase 12 antibodyAnti-Ek12 antibodyAnti-EPHA6 antibodyAnti-EHK2 antibodyAnti-HEK12 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
